Table 3 Healthcare resource utilization, costs, and charges during follow-up period
From: The healthcare burden of pulmonary alveolar proteinosis (PAP)
PAP cohort (N = 2312) | Matched control cohort (N = 9247) | P value | |||
|---|---|---|---|---|---|
Mean | SD | Mean | SD | ||
Outpatient visits | |||||
Patients with outpatient visit, n (%) | 2002 | 87% | 5142 | 56% | |
Number of outpatient visits, mean (SD) | 10.7 | 10.9 | 4.0 | 7 | < 0.001 |
Emergency room visits | |||||
Patients with emergency room visit, n (%) | 802 | 35% | 1260 | 14% | |
Number of emergency room visits, mean (SD) | 1.0 | 2.3 | 0.29 | 1 | < 0.001 |
Inpatient Visits | |||||
Patients with inpatient visit, n (%) | 467 | 20% | 424 | 5% | |
Number of inpatient visits, mean (SD) | 2.3 | 7.8 | 0.38 | 2.5 | < 0.001 |
Length of stay* | |||||
Length of stay (Days), mean (SD) | 2.8 | 7.6 | 0.56 | 2.9 | < 0.001 |
Pharmacy costs | |||||
Plan-paid, MEAN (SD) | $3685.45 | $17,531.58 | $839.44 | $6457.24 | < 0.001 |
Patient out-of-pocket, mean (SD) | $345.50 | $1276.07 | $153.24 | $836.45 | < 0.001 |
Non-pharmacy charges | |||||
Non-pharmacy charges, mean (SD) | $71,672.64 | $226,117.54 | $14,655.91 | $74,791.03 | < 0.001 |